{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:24:53Z","timestamp":1760059493884,"version":"build-2065373602"},"reference-count":46,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Background\/Objectives: Fibroproliferative disorders (FPDs), such as Dupuytren\u2019s contracture, scleroderma, capsular contracture, rhinophyma, and keloid scars, are characterised by excessive fibroblast activity and collagen deposition. These conditions are frequently encountered in plastic and reconstructive surgery and remain therapeutically challenging. Cyclooxygenase (COX) inhibitors have emerged as a potential adjunct therapy to modulate fibrotic pathways and improve clinical outcomes. This systematic review aims to evaluate the efficacy and safety profile of COX inhibitors in the management of plastic-surgery-related FPDs. In doing so, it explores how phenotype-guided and route-specific COX-inhibitor use may contribute to precision, patient-centred care. Methods: To identify eligible studies, a comprehensive search was conducted in MEDLINE, Embase, and the Cochrane Library. Data were synthesised using both tabular summaries and narrative analysis. The certainty of evidence was appraised according to the GRADE guidelines. Results: Thirteen studies from 1984 to 2024 met inclusion criteria, addressing FPDs such as hypertrophic scarring, Dupuytren\u2019s contracture, and desmoid tumours, representing 491 patients. Of those, five studies were related to Dupuytren contracture, three studies were related to hypertrophic scar, and one study each was on topics related to scleroderma, keloid scar, osteogenesis imperfecta, actinic keloidalis nuchae\/dissecting cellulitis of the scalp, and desmoid tumours. Nine studies reported clinical improvements (four demonstrating statistically significant outcomes), three showed no difference, and one did not assess outcomes. The thirteen studies show minor side effects from oral and topical COX inhibitors. The overall certainty of evidence was graded as \u201clow.\u201d Conclusions: COX inhibitors demonstrate promising efficacy with minimal adverse effects in the management of plastic-surgery-related FPDs. Their accessibility, safety, and potential to reduce fibrosis underscore the need for future high-quality, large-scale studies to establish definitive clinical recommendations.<\/jats:p>","DOI":"10.3390\/jpm15060257","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:52:47Z","timestamp":1750139567000},"page":"257","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of COX Inhibitors in Plastic Surgery Fibroproliferative Disorders: A Systematic Review"],"prefix":"10.3390","volume":"15","author":[{"given":"Yu Ting","family":"Tay","sequence":"first","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Eastern Health, Melbourne, VIC 3128, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6380-8160","authenticated-orcid":false,"given":"Elisha","family":"Purcell","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Peninsula Clinical School, Monash University, Melbourne, VIC 3199, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishith","family":"Seth","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Peninsula Clinical School, Monash University, Melbourne, VIC 3199, Australia"},{"name":"Department of Plastic and Reconstructive Surgery, Peninsula Health, Melbourne, VIC 3199, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8621-8216","authenticated-orcid":false,"given":"Gianluca","family":"Marcaccini","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, University of Siena, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4092-182X","authenticated-orcid":false,"given":"Warren M.","family":"Rozen","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Peninsula Clinical School, Monash University, Melbourne, VIC 3199, Australia"},{"name":"Department of Plastic and Reconstructive Surgery, Peninsula Health, Melbourne, VIC 3199, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/03008207.2011.642035","article-title":"Fibroproliferative Disorders and Their Mechanobiology","volume":"53","author":"Huang","year":"2012","journal-title":"Connect. Tissue Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases","volume":"117","author":"Wynn","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1186\/s12967-023-04690-7","article-title":"The impact of fibrotic diseases on global mortality from 1990 to 2019","volume":"21","author":"Mutsaers","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1742-481X.2012.01118.x","article-title":"Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings","volume":"11","author":"Huang","year":"2014","journal-title":"Int. Wound J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhsa.2021.07.005","article-title":"Dupuytren Contractures: An Update of Recent Literature","volume":"46","author":"Boe","year":"2021","journal-title":"J. Hand Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/SAP.0b013e31815f12d2","article-title":"Rhinophyma: Diagnosis and treatment options for a disfiguring tumor of the nose","volume":"61","author":"Sadick","year":"2008","journal-title":"Ann. Plast. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Sharma, V., Bhatia, P., Alam, O., Javed Naim, M., Nawaz, F., and Ahmad Sheikh, A. (2019). Recent advancement in the discovery and development of COX-2 inhibitors: Insight into biological activities and SAR studies (2008\u20132019). Bioorg. Chem., 89.","DOI":"10.1016\/j.bioorg.2019.103007"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S2213-2600(23)00125-X","article-title":"Knowledge gaps in fibrotic interstitial lung disease in pan-Asian populations: Data not missing at random?","volume":"11","author":"Chua","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.21037\/cdt.2019.08.07","article-title":"Challenges in addressing the knowledge gap on endomyocardial fibrosis through community-based studies","volume":"10","author":"Mbanze","year":"2020","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2059513119868659","DOI":"10.1177\/2059513119868659","article-title":"Keloid research: Current status and future directions","volume":"5","author":"Tsai","year":"2019","journal-title":"Scars Burn. Heal."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.1073\/pnas.1607896113","article-title":"Strategies to overcome the hurdles to treat fibrosis, a major unmet clinical need","volume":"113","author":"Nanchahal","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/SAP.0000000000001607","article-title":"Dupuytren\u2019s Contracture: An Evidence Based Review","volume":"81","author":"Mella","year":"2018","journal-title":"Ann. Plast. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.hcl.2018.03.007","article-title":"Complications of Treatment for Dupuytren Disease","volume":"34","author":"Eberlin","year":"2018","journal-title":"Hand Clin."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Alser, O., Craig, R.S., Lane, J.C.E., Prats-Uribe, A., Robinson, D.E., Rees, J.L., Prieto-Alhambra, D., and Furniss, D. (2020). Serious complications and risk of re-operation after Dupuytren\u2019s disease surgery: A population-based cohort study of 121,488 patients in England. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-73595-y"},{"key":"ref_15","unstructured":"Owais Qureshi, A.D. (2024). COX Inhibitors, StatPearls."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Jha, M., Nawaz, F., Naim, M.J., Sharma, V., Sheikh, A.A., Bhatia, P., and Alam, O. (2019). Recent advancement in the discovery and development of COX-2 inhibitors: Insight into biological activities and SAR studies (2008\u20132019). Bioorg. Chem., 89.","DOI":"10.1016\/j.bioorg.2019.103007"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/rheumatology\/kem070","article-title":"Combining enzyme specificity and tissue selectivity of cyclooxygenase inhibitors: Towards better tolerability?","volume":"46","author":"Brune","year":"2007","journal-title":"Rheumatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/DAD.0b013e3182a27b83","article-title":"Immunohistochemical evaluation of cox-1 and cox-2 expression in keloid and hypertrophic scar","volume":"36","author":"Abdou","year":"2014","journal-title":"Am. J. Dermatopathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevEukaryotGeneExpr.2024052889","article-title":"Inflammatory Markers Involved in the Pathogenesis of Dupuytren\u2019s Contracture","volume":"34","author":"Cates","year":"2024","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Fu, R., Zhou, S., Liu, C., Zhou, J., and Li, Q. (2024). Administration of a combination of COX-2\/TGF-\u03b21 siRNAs induces hypertrophic scar fibroblast apoptosis through a TP53 mediated caspase pathway. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-77756-1"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Sun, Q., Cai, J.-Q., Liu, Y.-Q., Cao, Y., Wang, Z.-C., Zhao, W.-Y., Tan, W.-Q., Shen, X.Z., and Shi, P. (2020). The Roles of Inflammation in Keloid and Hypertrophic Scars. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.603187"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejphar.2007.02.065","article-title":"Anti-fibrotic effect of meloxicam in a murine lung fibrosis model","volume":"564","author":"Arafa","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1568014053507122","article-title":"The Significance of COX-2 and COX-2 Inhibitors in Liver Fibrosis and Liver Cancer","volume":"4","author":"Cheng","year":"2005","journal-title":"Curr. Med. Chem. Anti-Inflamm. Anti-Allergy Agents"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1524-475X.2006.00193.x","article-title":"Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-beta1-induced collagen synthesis","volume":"15","author":"Sandulache","year":"2007","journal-title":"Wound Repair Regen."},{"key":"ref_25","first-page":"n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Int. J. Surg."},{"key":"ref_26","unstructured":"Li, T.H.J., Deeks, J.J., and Higgins, J.P.T. (2023). Chapter 5: Collecting data. Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (Updated August 2023), Cochrane."},{"key":"ref_27","unstructured":"Higgins, J.P.T.S.J., Page, M.J., Elbers, R.G., Sterne, J.A.C., and Higgins, J.P.T. (2023). Chapter 8: Assessing risk of bias in a randomized trial. Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (Updated August 2023), Cochrane."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.1780271009","article-title":"Trial of platelet-inhibiting drug in scleroderma double-blind study with dipyridamole and aspirin","volume":"27","author":"Chao","year":"1984","journal-title":"Arthritis Rheum."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/02844310151032691","article-title":"Acute Postoperative Swelling After Hand Surgery: An Exploratory, Double-Blind, Randomised Study with Paracetamol, Naproxen, and Placebo","volume":"35","author":"Husby","year":"2001","journal-title":"Scand. J. Plast. Reconstr. Surg. Hand Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1213\/ane.0b013e3181618831","article-title":"Perioperative Versus Postoperative Celecoxib on Patient Outcomes After Major Plastic Surgery Procedures","volume":"106","author":"Sun","year":"2008","journal-title":"Anesth. Analg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1097\/BCR.0000000000000427","article-title":"Anesthetic Practices for Laser Rehabilitation of Pediatric Hypertrophic Burn Scars","volume":"38","author":"Wong","year":"2017","journal-title":"J. Burn. Care Res."},{"key":"ref_35","first-page":"46","article-title":"An add-on therapy for neuropathic pain: Infiltration block with diclofenac sodium and lidocaine through the hypertrophic scar tissue","volume":"31","author":"Eker","year":"2019","journal-title":"J. Turk. Soc. Algol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhsg.2019.09.008","article-title":"Effect of Bupivacaine Liposome Injectable Suspension on Sensory Blockade and Analgesia for Dupuytren Contracture Release","volume":"1","author":"Mesotten","year":"2019","journal-title":"J. Hand Surg. Glob. Online"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jhsg.2019.10.004","article-title":"Acute Pain Intensity After Collagenase Clostridium histolyticum Injection in Patients with Dupuytren Contracture","volume":"2","author":"Noto","year":"2020","journal-title":"J. Hand Surg. Glob. Online"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/08880018.2020.1735591","article-title":"Combination therapy with sorafenib and celecoxib for pediatric patients with desmoid tumor","volume":"37","author":"Robles","year":"2020","journal-title":"Pediatr. Hematol. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejr.2021.04.001","article-title":"Osteogenesis imperfecta and Ledderhose disease: Is there a link? A report of two Tunisian siblings","volume":"43","author":"Boussaid","year":"2021","journal-title":"Egypt. Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"914e","DOI":"10.1097\/PRS.0000000000009038","article-title":"The Effect of Anticoagulation on the Treatment of Dupuytren Contracture with Collagenase","volume":"149","author":"Noland","year":"2022","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jdcr.2023.09.008","article-title":"Treatment of acne keloidalis nuchae and dissecting cellulitis of the scalp with diclofenac sodium gel: A case series","volume":"42","author":"Ibrahim","year":"2023","journal-title":"JAAD Case Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"123738","DOI":"10.1016\/j.ijpharm.2023.123738","article-title":"Asiatic acid-entrapped transfersomes for the treatment of hypertrophic scars: In vitro appraisal, bioactivity evaluation, and clinical study","volume":"651","author":"Opatha","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1142\/S2424835524500310","article-title":"Adjuvant Treatment with Celecoxib after Collagenase Injection for Dupuytren Contracture: A Double-Blind Randomised Controlled Trial","volume":"29","author":"Reyniers","year":"2024","journal-title":"J. Hand Surg. Asian Pac. Vol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0749-8063(05)80309-3","article-title":"The clinical effect of naproxen sodium after arthroscopy of the knee: A randomized, double-blind, prospective study","volume":"9","author":"Rasmussen","year":"1993","journal-title":"Arthroscopy"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/03009748409102671","article-title":"Naproxen Suppositories in Postoperative Pain and Swelling after Joint Surgery: A Comparative, Double-blind Study","volume":"13","author":"Kvarnes","year":"1984","journal-title":"Scand. J. Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4317\/medoral.19518","article-title":"Comparison of the effect of naproxen, etodolac and diclofenac on postoperative sequels following third molar surgery: A randomised, double-blind, crossover study","volume":"19","author":"Akbulut","year":"2014","journal-title":"Med. Oral Patol. Oral Cir. Bucal"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/15\/6\/257\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:53:23Z","timestamp":1760032403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/15\/6\/257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["jpm15060257"],"URL":"https:\/\/doi.org\/10.3390\/jpm15060257","relation":{},"ISSN":["2075-4426"],"issn-type":[{"type":"electronic","value":"2075-4426"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}